AG˹ٷ

STOCK TITAN

[144] Credit Acceptance Corp SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

Credit Acceptance Corp. (CACC) Form 144 filing: The Jill Foss Watson Living Trust intends to sell up to 40,000 common shares through UBS Securities on or after 29 Jul 2025. Based on the stated aggregate market value of $20.65 million, the implied price is about $516 per share. The planned sale equals roughly 0.34 % of CACC’s 11.60 million shares outstanding.

The trust acquired the shares in 2011 via a GRAT remainder transfer. During the past three months it already sold 20,000 shares (2 Jul 2025) for $15.87 million. The signatory affirms no undisclosed adverse information exists.

  • Class: Common stock
  • Broker: UBS Securities LLC, NYC
  • Planned exchange: NASDAQ

The notice does not alter corporate fundamentals but signals ongoing insider liquidity activity that investors may monitor for sentiment clues.

Deposito Modulo 144 di Credit Acceptance Corp. (CACC): Il Jill Foss Watson Living Trust intende vendere fino a 40.000 azioni ordinarie tramite UBS Securities a partire dal 29 luglio 2025. Basandosi sul valore di mercato aggregato dichiarato di 20,65 milioni di dollari, il prezzo implicito è di circa 516 dollari per azione. La vendita prevista rappresenta circa il 0,34% delle 11,60 milioni di azioni in circolazione di CACC.

Il trust ha acquisito le azioni nel 2011 tramite un trasferimento residuo GRAT. Negli ultimi tre mesi ha già venduto 20.000 azioni (il 2 luglio 2025) per un valore di 15,87 milioni di dollari. Il firmatario conferma che non esistono informazioni negative non divulgate.

  • Classe: Azioni ordinarie
  • Broker: UBS Securities LLC, NYC
  • Mercato previsto: NASDAQ

La comunicazione non modifica i fondamentali aziendali, ma segnala un’attività di liquidità interna in corso che gli investitori potrebbero monitorare per rilevare segnali di sentiment.

Presentación del Formulario 144 de Credit Acceptance Corp. (CACC): El Jill Foss Watson Living Trust planea vender hasta 40,000 acciones ordinarias a través de UBS Securities a partir del 29 de julio de 2025. Basado en el valor de mercado agregado declarado de 20.65 millones de dólares, el precio implícito es aproximadamente 516 dólares por acción. La venta planificada equivale aproximadamente al 0.34% de las 11.60 millones de acciones en circulación de CACC.

El trust adquirió las acciones en 2011 mediante una transferencia residual GRAT. En los últimos tres meses ya vendió 20,000 acciones (el 2 de julio de 2025) por un total de 15.87 millones de dólares. El firmante afirma que no existe información adversa no revelada.

  • Clase: Acciones ordinarias
  • Corredor: UBS Securities LLC, NYC
  • Bolsa prevista: NASDAQ

El aviso no modifica los fundamentos corporativos, pero indica una actividad continua de liquidez interna que los inversores pueden monitorear para obtener pistas sobre el sentimiento.

Credit Acceptance Corp. (CACC) Form 144 제출: Jill Foss Watson Living Trust� 2025� 7� 29� 또는 � 이후� UBS Securities� 통해 최대 40,000 보통�� 매도� 예정입니�. 명시� � 시장 가� 2,065� 달러� 기준으로 주당 가격은 � 516달러입니�. 계획� 매도� CACC� � 발행 주식 1,160� 주의 � 0.34%� 해당합니�.

해당 트러스트� 2011년에 GRAT 잔여 이전� 통해 주식� 취득했습니다. 지� 3개월 동안 이미 20,000�(2025� 7� 2�)� 1,587� 달러� 매도했습니다. 서명자는 공개되지 않은 부정적 정보가 없음� 확인합니�.

  • 종류: 보통�
  • 중개�: UBS Securities LLC, 뉴욕
  • 예정 거래�: NASDAQ

이번 공시� 기업� 기본 사항� 변경하지 않지�, 투자자들� 심리 동향� 파악하기 위해 주시� � 있는 내부� 유동� 활동� 시사합니�.

Dépôt du formulaire 144 de Credit Acceptance Corp. (CACC) : Le Jill Foss Watson Living Trust prévoit de vendre jusqu'à 40 000 actions ordinaires via UBS Securities à partir du 29 juillet 2025. Sur la base de la valeur de marché agrégée déclarée de 20,65 millions de dollars, le prix implicite est d'environ 516 dollars par action. La vente prévue représente environ 0,34 % des 11,60 millions d'actions en circulation de CACC.

Le trust a acquis les actions en 2011 via un transfert résiduel GRAT. Au cours des trois derniers mois, il a déjà vendu 20 000 actions (le 2 juillet 2025) pour 15,87 millions de dollars. Le signataire confirme qu'aucune information défavorable non divulguée n'existe.

  • Catégorie : Actions ordinaires
  • Intermédiaire : UBS Securities LLC, NYC
  • Bourse prévue : NASDAQ

L'avis ne modifie pas les fondamentaux de la société, mais signale une activité continue de liquidité interne que les investisseurs peuvent surveiller pour détecter des indices de sentiment.

Credit Acceptance Corp. (CACC) Form 144 Einreichung: Der Jill Foss Watson Living Trust beabsichtigt, bis zu 40.000 Stammaktien über UBS Securities am oder nach dem 29. Juli 2025 zu verkaufen. Basierend auf dem angegebenen aggregierten Marktwert von 20,65 Millionen US-Dollar ergibt sich ein impliziter Preis von etwa 516 US-Dollar pro Aktie. Der geplante Verkauf entspricht etwa 0,34 % der 11,60 Millionen ausstehenden CACC-Aktien.

Der Trust erwarb die Aktien 2011 durch eine GRAT-Restübertragung. In den letzten drei Monaten wurden bereits 20.000 Aktien (2. Juli 2025) für 15,87 Millionen US-Dollar verkauft. Der Unterzeichner bestätigt, dass keine nicht offengelegten negativen Informationen vorliegen.

  • Klasse: Stammaktien
  • Broker: UBS Securities LLC, NYC
  • Geplanter Handelsplatz: NASDAQ

Die Mitteilung ändert die Unternehmensgrundlagen nicht, signalisiert jedoch eine fortlaufende Insider-Liquiditätsaktivität, die Anleger zur Stimmungsbeobachtung nutzen können.

Positive
  • Transparent compliance with Rule 144 and affirmation of no undisclosed adverse information.
  • Sale size is modest, representing only ~0.34 % of shares outstanding, limiting dilution/overhang risk.
Negative
  • Continued insider selling (60k shares within a month) can be viewed as a bearish signal on near-term prospects.
  • Potential supply overhang of $20.7 m worth of stock may pressure short-term trading sentiment.

Insights

TL;DR Insider trust plans 40k-share sale (~$20.7 m); modest 0.34 % of float, but follows recent 20k-share sale—sentiment mildly negative.

The filing reveals continued disposition by the Jill Foss Watson Living Trust. While the absolute stake is small relative to CACC’s float, cumulative 60k shares in one month (~0.5 %) may raise questions on insider outlook. Rule 144 sales are routine, yet timing near prior sale could pressure near-term trading and signal limited upside conviction.
No operational data is provided, so financial impact is limited to potential supply overhang. Investors typically discount one-off liquidity events; repeated sales warrant closer monitoring.

TL;DR Routine Rule 144 filing; compliance intact, disclosure transparent—impact neutral barring market perception of insider intent.

The trust follows proper Rule 144 disclosure, naming broker, share count, and acquisition history. Affirmation of no undisclosed MNPI reduces legal risk. Governance view: transaction appears planned (possibly under 10b5-1) and does not, in itself, suggest governance weakness. Market may interpret serial sales negatively, but from a compliance standpoint the company maintains best practices.

Deposito Modulo 144 di Credit Acceptance Corp. (CACC): Il Jill Foss Watson Living Trust intende vendere fino a 40.000 azioni ordinarie tramite UBS Securities a partire dal 29 luglio 2025. Basandosi sul valore di mercato aggregato dichiarato di 20,65 milioni di dollari, il prezzo implicito è di circa 516 dollari per azione. La vendita prevista rappresenta circa il 0,34% delle 11,60 milioni di azioni in circolazione di CACC.

Il trust ha acquisito le azioni nel 2011 tramite un trasferimento residuo GRAT. Negli ultimi tre mesi ha già venduto 20.000 azioni (il 2 luglio 2025) per un valore di 15,87 milioni di dollari. Il firmatario conferma che non esistono informazioni negative non divulgate.

  • Classe: Azioni ordinarie
  • Broker: UBS Securities LLC, NYC
  • Mercato previsto: NASDAQ

La comunicazione non modifica i fondamentali aziendali, ma segnala un’attività di liquidità interna in corso che gli investitori potrebbero monitorare per rilevare segnali di sentiment.

Presentación del Formulario 144 de Credit Acceptance Corp. (CACC): El Jill Foss Watson Living Trust planea vender hasta 40,000 acciones ordinarias a través de UBS Securities a partir del 29 de julio de 2025. Basado en el valor de mercado agregado declarado de 20.65 millones de dólares, el precio implícito es aproximadamente 516 dólares por acción. La venta planificada equivale aproximadamente al 0.34% de las 11.60 millones de acciones en circulación de CACC.

El trust adquirió las acciones en 2011 mediante una transferencia residual GRAT. En los últimos tres meses ya vendió 20,000 acciones (el 2 de julio de 2025) por un total de 15.87 millones de dólares. El firmante afirma que no existe información adversa no revelada.

  • Clase: Acciones ordinarias
  • Corredor: UBS Securities LLC, NYC
  • Bolsa prevista: NASDAQ

El aviso no modifica los fundamentos corporativos, pero indica una actividad continua de liquidez interna que los inversores pueden monitorear para obtener pistas sobre el sentimiento.

Credit Acceptance Corp. (CACC) Form 144 제출: Jill Foss Watson Living Trust� 2025� 7� 29� 또는 � 이후� UBS Securities� 통해 최대 40,000 보통�� 매도� 예정입니�. 명시� � 시장 가� 2,065� 달러� 기준으로 주당 가격은 � 516달러입니�. 계획� 매도� CACC� � 발행 주식 1,160� 주의 � 0.34%� 해당합니�.

해당 트러스트� 2011년에 GRAT 잔여 이전� 통해 주식� 취득했습니다. 지� 3개월 동안 이미 20,000�(2025� 7� 2�)� 1,587� 달러� 매도했습니다. 서명자는 공개되지 않은 부정적 정보가 없음� 확인합니�.

  • 종류: 보통�
  • 중개�: UBS Securities LLC, 뉴욕
  • 예정 거래�: NASDAQ

이번 공시� 기업� 기본 사항� 변경하지 않지�, 투자자들� 심리 동향� 파악하기 위해 주시� � 있는 내부� 유동� 활동� 시사합니�.

Dépôt du formulaire 144 de Credit Acceptance Corp. (CACC) : Le Jill Foss Watson Living Trust prévoit de vendre jusqu'à 40 000 actions ordinaires via UBS Securities à partir du 29 juillet 2025. Sur la base de la valeur de marché agrégée déclarée de 20,65 millions de dollars, le prix implicite est d'environ 516 dollars par action. La vente prévue représente environ 0,34 % des 11,60 millions d'actions en circulation de CACC.

Le trust a acquis les actions en 2011 via un transfert résiduel GRAT. Au cours des trois derniers mois, il a déjà vendu 20 000 actions (le 2 juillet 2025) pour 15,87 millions de dollars. Le signataire confirme qu'aucune information défavorable non divulguée n'existe.

  • Catégorie : Actions ordinaires
  • Intermédiaire : UBS Securities LLC, NYC
  • Bourse prévue : NASDAQ

L'avis ne modifie pas les fondamentaux de la société, mais signale une activité continue de liquidité interne que les investisseurs peuvent surveiller pour détecter des indices de sentiment.

Credit Acceptance Corp. (CACC) Form 144 Einreichung: Der Jill Foss Watson Living Trust beabsichtigt, bis zu 40.000 Stammaktien über UBS Securities am oder nach dem 29. Juli 2025 zu verkaufen. Basierend auf dem angegebenen aggregierten Marktwert von 20,65 Millionen US-Dollar ergibt sich ein impliziter Preis von etwa 516 US-Dollar pro Aktie. Der geplante Verkauf entspricht etwa 0,34 % der 11,60 Millionen ausstehenden CACC-Aktien.

Der Trust erwarb die Aktien 2011 durch eine GRAT-Restübertragung. In den letzten drei Monaten wurden bereits 20.000 Aktien (2. Juli 2025) für 15,87 Millionen US-Dollar verkauft. Der Unterzeichner bestätigt, dass keine nicht offengelegten negativen Informationen vorliegen.

  • Klasse: Stammaktien
  • Broker: UBS Securities LLC, NYC
  • Geplanter Handelsplatz: NASDAQ

Die Mitteilung ändert die Unternehmensgrundlagen nicht, signalisiert jedoch eine fortlaufende Insider-Liquiditätsaktivität, die Anleger zur Stimmungsbeobachtung nutzen können.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many CACC shares are being sold under this Form 144?

The trust plans to sell 40,000 common shares.

What is the aggregate market value of the planned CACC sale?

The filing lists an aggregate market value of $20.65 million.

What percentage of Credit Acceptance Corp’s float does 40,000 shares represent?

Approximately 0.34 % of the 11.60 million shares outstanding.

When is the earliest sale date for the CACC shares?

The notice specifies 29 July 2025 as the approximate sale date.

Has the filer sold CACC shares recently?

Yes. The same trust sold 20,000 shares on 2 Jul 2025 for $15.87 million.

Who is acting as broker for the transaction?

The shares will be sold through UBS Securities LLC, New York on NASDAQ.
Credit Accep Corp Mich

NASDAQ:CACC

CACC Rankings

CACC Latest News

CACC Latest SEC Filings

CACC Stock Data

5.99B
6.22M
39.07%
65.81%
3.42%
Credit Services
Personal Credit Institutions
United States
SOUTHFIELD